# K121313: MTF New Bone Void Filler

- Pathway: 510(k) (Traditional)
- Applicant: Musculoskeletal Transplant Foundation
- Decided: Jan 11, 2013 after 254 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K042829 (2006). 8 ancestors in all.
No later device cites it as a predicate yet.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K110003: MTF New Bone Void Filler, Musculoskeletal Transplant Foundation (2011) Summary page 1.
- K113167: MTF New Bone Voild Filler, Musculoskeletal Transplant Foundation (2012) Summary page 1.
- K040262: DBX Demineralized Bone Matrix Putty, Bone Matrix Paste and Bone Matrix Mix, Musculoskeletal Transplant Foundation (2005) Summary page 1.
- K103784: DBX Demineralized Bone Matrix Putty, Musculoskeletal Transplant Foundation (2011) Summary page 1.
- K103795: DBX Demineralized Bone Matrix Putty, Musculoskeletal Transplant Foundation (2011) Summary page 1.
- K042829: DBX Strip, Musculoskeletal Transplant Foundation (2006) Summary page 1.
- K062205: DBX Strip, Musculoskeletal Transplant Foundation (2007) Summary page 1.

## Indications for use
The MTF New Bone Void Filler is intended for use as a Demineralized Bone Matrix for voids or gaps that are not intrinsic to the stability of the bony structure. The MTF New Bone Void Filler is indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. The MTF New Bone Void Filler must be used in the posterolateral spine with bone marrow aspirate or autograft. The MTF New Bone Void Filler is for single patient use only.

Source page: https://510kreport.com/device/K121313
Methodology: https://510kreport.com/methodology